HK1209363A1 - Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases - Google Patents

Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases

Info

Publication number
HK1209363A1
HK1209363A1 HK15110189.3A HK15110189A HK1209363A1 HK 1209363 A1 HK1209363 A1 HK 1209363A1 HK 15110189 A HK15110189 A HK 15110189A HK 1209363 A1 HK1209363 A1 HK 1209363A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
rheumatoid arthritis
related diseases
lactobacillus crispatus
Prior art date
Application number
HK15110189.3A
Other languages
Chinese (zh)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1209363A1 publication Critical patent/HK1209363A1/en

Links

HK15110189.3A 2014-09-30 2015-10-16 Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases HK1209363A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410522392.8A CN104546947B (en) 2014-09-30 2014-09-30 Lactobacillus crispatus is treating or preventing the application in rheumatoid arthritis

Publications (1)

Publication Number Publication Date
HK1209363A1 true HK1209363A1 (en) 2016-04-01

Family

ID=53064719

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110189.3A HK1209363A1 (en) 2014-09-30 2015-10-16 Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases

Country Status (2)

Country Link
CN (1) CN104546947B (en)
HK (1) HK1209363A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106562998A (en) * 2015-10-12 2017-04-19 深圳华大基因研究院 Applications of lactobacillus crispatus in treatment or prevention of uterus myoma related diseases
CN108546663B (en) * 2018-05-10 2020-06-16 北京市农林科学院 Porcine lactobacillus crispatus and application thereof
JP7442195B2 (en) 2018-05-23 2024-03-04 コバイオラブズ・インコーポレイテッド Lactobacillus crispatus KBL693 strain and its use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8194951B2 (en) * 2005-09-30 2012-06-05 Philips Electronics North Method and system for generating display data
CN101454439B (en) * 2006-05-31 2011-01-26 明治乳业株式会社 Method for culture of lactic acid bacterium having high immunomodulating activity
CN102115721B (en) * 2008-05-08 2012-09-26 景岳生物科技股份有限公司 Lactobacillus isolated strains with anti-inflammatory activity and use thereof
WO2013021957A1 (en) * 2011-08-05 2013-02-14 株式会社ヤクルト本社 Prophylactic or therapeutic agent for oral diseases
CN103074270A (en) * 2012-11-15 2013-05-01 上海交大昂立股份有限公司 Lactobacillus crispatus and application
CN103911305B (en) * 2013-01-05 2016-04-13 欣力菲生物医药技术（天津）有限公司 Lactobacillus crispatus bacterial strain and uses thereof

Also Published As

Publication number Publication date
CN104546947B (en) 2019-01-08
CN104546947A (en) 2015-04-29

Similar Documents

Publication Publication Date Title
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
HK1209349A1 (en) Use of parabacteroides merdae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209360A1 (en) Use of bacteroides ovatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209347A1 (en) Use of bacteroides dorei in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209350A1 (en) Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209365A1 (en) Use of bacteroides plebeius in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209348A1 (en) Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseases
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
HK1245658A1 (en) Nutritional composition useful in the treatment of ibd patients
PL3277280T3 (en) Isomyosmine for use in the treatment of autoimmune diseases
ZA201704726B (en) Peptides and their use in the treatment of skin
HK1209346A1 (en) Use of bifidobacterium bifidum in the treatment or prevention of rheumatoid arthritis or related diseases
HK1249851A1 (en) Treatment and prevention of the common cold using povidone-iodine
PL3160464T3 (en) 6-hydroxybuspirone for use in the treatment of movement disorders
HK1209351A1 (en) Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases
PT3177599T (en) Fumarate analogs and uses thereof in the treatment of an autoimmune disease or an inflammatory disease
HK1209359A1 (en) Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases
GB201404372D0 (en) Assay and treatment
FI3197556T3 (en) Composition for the prevention and/or treatment of allergy symptoms
HK1209363A1 (en) Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209366A1 (en) Use of lactococcus lactis in the treatment or prevention of rheumatoid arthritis or related diseases
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
HK1209357A1 (en) Use of dialister invisus in the treatment or prevention of rheumatoid arthritis or related diseases
PT3234597T (en) Proteins of the wnt signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders
PT3191112T (en) Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation